Beck Bode LLC Has $583,000 Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Beck Bode LLC reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 30.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 4,406 shares of the financial services provider’s stock after selling 1,900 shares during the quarter. Beck Bode LLC’s holdings in iShares Biotechnology ETF were worth $583,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. HHM Wealth Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares during the last quarter. VSM Wealth Advisory LLC bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $30,000. Bradley & Co. Private Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at about $32,000. Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $33,000. Finally, Hager Investment Management Services LLC bought a new position in iShares Biotechnology ETF during the 4th quarter worth $34,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

IBB opened at $126.60 on Friday. The firm has a market cap of $5.54 billion, a P/E ratio of 25.09 and a beta of 0.84. The business’s fifty day moving average is $126.97 and its 200-day moving average is $134.32. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $150.57.

iShares Biotechnology ETF Increases Dividend

The company also recently announced a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were issued a $0.1212 dividend. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.